| 查看: 313 | 回复: 0 | ||
| 【悬赏金币】回答本帖问题，作者haoqiongyu将赠送您 5 个金币 | ||
[求助]
美国Charles R. Drew University招聘博士后、 访问学生、访问学者.
|
||
|
郝穹予博士于2015年在厦门大学取得博士学位。之后前往美国从事博士后研究，现在为Charles R. Drew University of Medicine and Science（CDU）Assistant Professor，从事癌症多样性的基础研究。Dr. Hao实验室科研经费充足，实验仪器设备先进完备，目前几个课题有很好的前期积累，期待highly motivated，ambitiuos 博士后、 访问学生、访问学者加入我们的团队。我们会提供给博士后有竞争性的薪资，优秀的visiting博士生、访问学者根据表现也会得到相应的奖励。郝穹予博士也会帮助你以后的职业发展。CDU位于美国加州洛杉矶，气候宜人、生活便利。感兴趣的同学请发CV和personel statement到email：qiongyuhao@cdrewu.edu/haoqiongyu@gmail.com。也欢迎感兴趣的同学前来询问。 The Hao Laboratory in the Division of Cancer Research and Training at Charles R. Drew University of Medicine and Science (CDU) is seeking a highly motivated and talented Postdoctoral Research Fellow to join our team. Charles R. Drew University of Medicine and Science is a private university in Los Angeles, California US. Research at CDU focuses on ways to address health disparities within the state of California, nationally, and globally. Faculty members at CDU conduct ongoing NIH and DoD-funded research on conditions such as cancer, hypertension, diabetes, tobacco use and HIV/AIDs. Dr. Qiongyu Hao received his Ph.D. from Xiamen University in China. He pursued postdoctoral training at Albany Medical Center in Albany, NY, followed by a second postdoctoral fellowship at the New York University School of Medicine. He later joined the Division of Cancer Research and Training at Charles R. Drew University (CDU), where he conducts breast cancer research and was appointed as an Assistant Professor. Currently, Dr. Hao lab focuses on two major research areas: Exosome Biology – Understanding how exosomes function as biological nanovesicles that mediates communication in the tumor microenvironment (TME). Cancer Metabolism-investigating the non-coding RNAs and their role in epigenetic regulation of metabolic abnormalities-associated cancer. Dr. Hao's laboratory utilizes the cutting-edge resources of the RCMI AXIS Research Infrastructure Core, through innovative approaches, aims to uncover novel regulatory mechanisms driving cancer progression and identify potential therapeutic targets. We are seeking a dedicated and curious scientist with a Ph.D. in molecular biology, cancer biology, cell biology, biochemistry, or a related field. The ideal candidate will have experience in cancer signaling, RNA biology, or extracellular vesicle research. Strong analytical and communication skills, a collaborative spirit, and the ability to work independently are essential. As a postdoctoral fellow in our lab, you will play a key role in designing and conducting experiments using a range of advanced techniques. You’ll have access to the RCMI AXIS Research Core, which houses cutting-edge technologies such as: Next-generation sequencing (NGS); Super-resolution confocal microscopy; Mass spectrometry; Imaging flow cytometry; Automated imaging and bioinformatics platforms. You’ll be responsible for analyzing data, interpreting results, preparing manuscripts, and presenting findings at national and international scientific meetings. You’ll also have opportunities to contribute to grant proposals and mentor students. As part of our team, you’ll work in a supportive environment that values mentorship, collaboration, and scientific excellence. Our NIH-funded lab provides a solid foundation for postdoctoral fellows seeking to build strong publication records and prepare for independent research careers. If this opportunity resonates with your interests and career goals, please send your current CV and a cover letter outlining your research experience and career interests to Dr. Qiongyu Hao at:📧 qiongyuhao@cdrewu.edu or haoqiongyu@gmail.com. Applications will be reviewed on a rolling basis, and the position will remain open until filled. Charles R. Drew University is an equal opportunity employer committed to diversity, equity, and inclusion in all aspects of academic life. |
回复此楼» 猜你喜欢
康复大学泰山学者周祺惠团队招收博士研究生
已经有6人回复
-
AI论文写作工具：是科研加速器还是学术作弊器？
已经有3人回复
-
孩子确诊有中度注意力缺陷
已经有6人回复
-
2026博士申请-功能高分子，水凝胶方向
已经有6人回复
-
论文投稿，期刊推荐
已经有4人回复
-
硕士和导师闹得不愉快
已经有13人回复
-
请问2026国家基金面上项目会启动申2停1吗
已经有5人回复
-
同一篇文章，用不同账号投稿对编辑决定是否送审有没有影响？
已经有3人回复
-
RSC ADV状态问题
已经有4人回复
